Zobrazeno 1 - 10
of 199
pro vyhledávání: '"K, Lüdecke"'
Autor:
Markus Glatzel, Wolfgang Saeger, Jannik von Schöning, Ulrich J. Knappe, Dieter K. Lüdecke, Michael Buchfelder, Rof Buslei, Jörg Flitsch, Rundolph Fahlbusch, Jochen Herms, Walter J. Schulz-Schaeffer, Markus Bergmann
Publikováno v:
Hormones. 21:653-663
Purpose/Objective Multiple tumorous lesions in one pituitary gland are rare and mostly described in case reports. Their incidences and combinations are defined in larger collectives. Therefore, we analyzed our large collection for double tumors and c
Autor:
Rolf Buslei, Michael Buchfelder, Rudolf Fahlbusch, Jörg Flitsch, Markus Bergmann, Dieter K. Lüdecke, J. Warmbier, J. Kreutzer, Markus Glatzel, Ulrich J. Knappe, Wolfgang Saeger, Frank L. Heppner
Publikováno v:
Pituitary. 25(1)
Inflammatory pituitary lesions account for 1.8% of all specimens from the German Pituitary Tumor Registry. They occure in 0.5% of the autoptical specimens and in 2.2% of the surgical cases. Women are significantly more often affected than men and are
Publikováno v:
Endocrine pathology. 5(4)
To assess the proliferative activity of pituitary adenomas, 36 surgically removed adenomas were studied by light microscopical parameters; mitotic count; expression of PCNA, Ki-67, cathepsin D, and EGF; and image cytometry. Three adenomas (9%) showed
Publikováno v:
Endocrine pathology. 3(4)
Eighty-nine ACTH-secreting pituitary adenomas from patients with Cushing’s disease or Nelson’s syndrome were investigated by immunohistochemical methods for their content of gastrin, cholecystokinin (CCK), vasoactive intestinal peptide (VIP), bom
Publikováno v:
Endocrine pathology. 1(1)
Clinically inactive adenomas represent 30.7% of all pituitary tumors in our surgical collection of 616 cases. Ninety-six tumors were studied immunohistologically with many antibodies for their hormone content. Morphological classification of these ad
Autor:
Uirich J, Knappe, Dieter K, Lüdecke, Maximilian J A, Puchner, Wolfgang, Saeger, Hans-D, Herrmann
Publikováno v:
Endocrine pathology. 2(4)
Tissue from 23 pituitary adenomas causing Cushing's disease was implanted subcutaneously into 159 NuNu/NMRi mice, resected after 21 or 35 days, and evaluated histologically and immunohistochemically. After 21 days, 74.3% of the grafts survived, 59% h
Publikováno v:
Endocrine pathology. 1(2)
From 751 patients with suspected pituitary tumor, 2,354 frozen sections were prepared for histological identification of the tissue and determination of the resection margins after selective adenoma removal. The accuracy of the method was determined
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Journal of pediatric endocrinologymetabolism : JPEMReferences. 31(9)
BackgroundTransnasal surgery (TNS) is the first choice in the treatment of pediatric Cushing’s disease. The question is how can high remission rates be achieved with minimally invasive investigations and TNS whilst avoiding radiotherapy or bilatera
Autor:
Ulrich J. Knappe, Michael Buchfelder, Rudolf Fahlbusch, Rolf Buslei, Maximilian Müller, Patricia Crock, Jörg Flitsch, Wolfgang Saeger, Dieter K. Lüdecke
Publikováno v:
World neurosurgery. 119
Background Recurrences of pituitary adenomas are not so rare. Methods In the German Registry of Pituitary Tumors, more than 12,000 surgical specimens were collected between 1967 and 2012, of which 312 patients with altogether 334 recurrences (n = 646